Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of prepn. contg. extractive of red-rooted salvia in medicine of anti-aspirin-resistance

An aspirin and extract technology, applied in the field of medicine, can solve problems such as aspirin resistance

Inactive Publication Date: 2006-01-25
TIANJIN TASLY PHARMA CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to alleviate the phenomenon of aspirin resistance that occurs when cardiovascular and cerebrovascular patients use aspirin drugs to treat cardiovascular and cerebrovascular diseases, some scientific researchers are currently looking for drugs that can replace or alleviate the phenomenon of aspirin resistance. Some drugs are tested in order to find new uses of their drugs to solve the phenomenon of aspirin resistance caused by current aspirin use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Take 20g of salvia miltiorrhiza extract, 10g of antelope horn powder, 20g of ginseng, 18g of notoginseng, 20g of angelica, 6g of toad venom, 40g of pig gall paste, 5g of borneol, and 4g of musk for later use;

[0047] The above nine flavors, angelica, panax notoginseng, ginseng, and toads are mixed and pulverized to the finest powder, then mixed with other medicinal flavors, divided into 888 capsules, and the product is ready.

Embodiment 2

[0049] Take 5g of salvia miltiorrhiza extract, 5g of antelope horn powder, 10g of ginseng, 9g of notoginseng, 10g of angelica, 3g of toad venom, 20g of pig gall paste, 2.5g of borneol, and 2g of musk for later use;

[0050] The above nine flavors, angelica, panax notoginseng, ginseng, and toads are mixed and pulverized to the finest powder, then mixed with other medicinal flavors, divided into 888 capsules, and the product is ready.

Embodiment 3

[0052] Take 40g of salvia miltiorrhiza extract, 15g of antelope horn powder, 30g of ginseng, 15g of notoginseng, 20g of angelica, 8g of toad venom, 30g of pig gall paste, 5g of borneol, and 4g of musk for later use;

[0053] The above nine flavors, angelica, panax notoginseng, ginseng, and toads are mixed and pulverized to the finest powder, then mixed with other medicinal flavors, divided into 888 capsules, and the product is ready.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for treating the aspirin-resistant cardiovascular disease is prepared from 9 Chinese-medicinal materials including red sage root, ginseng, Chinese angelica root, borneol, etc.

Description

technical field [0001] The invention relates to the field of medicine, in particular, the invention relates to the application of a medicine in the preparation of medicine for treating aspirin resistance. Background technique [0002] Aspirin, also known as aspirin or acetylsalicylic acid, has been used clinically for more than 80 years and is an ancient antipyretic and analgesic. In recent years, with the in-depth study of prostaglandins, a new understanding of aspirin has emerged: in addition to traditionally used for antipyretic, analgesic, and anti-inflammatory clinically, it is also used for anti-platelet aggregation and so on. Clinical trials have shown that aspirin is an effective antiplatelet drug for the primary prevention of high-risk patients with cardiovascular and cerebrovascular diseases, and is also effective for the secondary prevention of myocardial infarction and ischemic vascular events. [0003] However, at present, when aspi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/53A61K36/258A61K36/25A61K36/232A61K9/00A61P9/10
Inventor 李永强郑永锋李旭
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products